Recent Company News

• 09:19 AM ET Oct 31, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 05:43 AM ET Oct 31, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:02 AM ET Nov 25, 2025
  

  Nanobiotix reports Q3 cash and cash equivalents €20.4M as of 30-Sep (24-Nov, post EU close) (€18.00, -0.82)

• 07:28 PM ET Nov 17, 2025
  

  Transcript Intelligence: Nanobiotix at Jefferies Global Healthcare Conference (€19.56, 0.00)

• 04:37 PM ET Nov 13, 2025
  

  Nanobiotix announces advancements for its next-wave Curadigm Nanoprimer platform. (€17.76, 0.00)

• 08:19 AM ET Oct 31, 2025
  

  StreetAccount Summary - US Pre-market trading

• 03:05 AM ET Oct 31, 2025
  

  Nanobiotix announces strategic royalty monetization agreement with Healthcare Royalty for up to $71M; financing extends cash runway into early 2028 (€16.36, 0.00)